|
|
Exploration of development strategy of hospital preparations in hospital based on SWOT analysis |
WANG Chenguang LIU Xiaoliang ZHAO Huaping CAO Guoying▲ |
National Center of Gerontology, Beijing Hospital, Beijing 100730, China |
|
|
Abstract Beijing Hospital (“our hospital” for short) preparations has a long history. Our staff and resources are well-configured and the management system is scientific and efficient. We have always strictly implemented the GPP for production, testing, storage and distribution. The preparation varieties are consistent with the medical characteristics of our hospital and it is well known in Beijing. The downside is that the hardware conditions limit the expansion of production, so it can not suit the clinical needs. And we are week in the new formulation development technology. For a long time the pricing is too low, so we suffered heavy losses. Using SWOT method to analyze the development trend of the preparation in our hospital, combined with current situation of hospital preparations and the new healthcare reform to explore the development strategy of hospital preparations, increase R&D investment, expand production, strengthen the introduction of qualified personnel, develop new varieties to better adapt to academic development and clinical needs.
|
|
|
|
|
[1] 国家食品药品监督管理局.医疗机构制剂注册管理办法[J].中国药事,2005,19(7):387.
[2] 仇为民.SWOT分析法在药剂科改革中的应用价值探讨[J].临床合理用药杂志,2016,9(27):174-175.
[3] 北京市食品药品监督管理局.北京市医疗机构制剂规程[S].2014年版·第一册.北京:中国商业出版社,2014:81-83,162.
[4] 崔乐.13种儿科“小名药”获准在市属医院儿科调剂[N].北京日报,2017-1-17(10).
[5] 申琳.北京市医疗机构制剂应用现状调研与对策研究[D].北京:北京中医药大学,2015.
[6] 汪延安,严会敏.GPP实施过程中的物料管理问题[J].中国药师,2005,8(2):171.
[7] 曹国颖,胡欣,孙钊,等.医疗机构制剂生产的风险因素分析与管控[J].中国药事,2018,31(1):30-33.
[8] 郭玉东.北京市食品药品监督管理局关于征求《北京市医疗机构制剂注册管理办法实施细则(征求意见稿)》意见的通知[EB/OL].北京:北京市食品药品监督管理局,2014[2014-07-29].http://www.bjfda.gov.cn/bjfda/zwgk29/gzdt14/tzgg/tz/212702/index.html
[9] 北京市药品监督管理局.北京市医疗机构制剂再注册和标准整顿工作方案[Z].京药监注[2010]10号,2010.
[10] 国家执业药师资格考试指导丛书编委会.药学综合知识与技能[M].北京:人民军医出版社,2006:8.
[11] 康荣荣,杨苏芳,韩萌,等.微乳在经皮给药系统中的应用[J].中南药学,2014,12(3):253-258.
[12] 张先洲,孟书舫,潘细贵,等.灯盏花素微乳的相图及处方优化[J].中国医院药学杂志,2014,34(24):2131-2134, 2157.
[13] 张新忠,唐婷,沈奇英.环糊精包合物脂质体的制备及其在药剂学上的应用[J].健康研究,2017,37(6):635-637.
[14] 刘肖,庞建云,刘娟,等.呋喃西林纳米混悬凝胶剂的制备及体外透皮评价[J].中国新药杂志,2017,26(24):3003-3008.
[15] 程静,梅蕊,刘忠,等.复方硝酸甘油凝胶对大鼠皮肤溃疡创面的调节作用[J]. 医药导报,2015,34(12):1591-1594.
[16] 谷福根,马维娜,王毅,等.利培酮鼻用凝胶剂在大鼠体内的药动学及脑靶向性研究[J].中国药学杂志,2017, 52(24):2179-2184.
[17] 程树仓.姜黄素纳米脂质载体温敏原位凝胶剂的研制[D].济南:山东大学,2013.
[18] 孙中英,王小宁.药物制剂新技术在中药制剂现代化中的应用[J].化工设计通讯,2017,43(9):183.
[19] 何伟.载药纳米粒制备的研究进展[J].中国医药导报,2016,13(14):33-36
[20] 杨小侠,林华庆,陈琼,等.新型植物卡拉胶软胶囊处方及工艺研究[J].亚太传统医药,2017,13(17):23-30.
[21] 韩丽妹,付艳,张丽红,等.新型药用辅料对复方丹参片药剂学性质及溶出性能的影响[J].复旦学报:医学版,2011,38(3):233-236. |
|
|
|